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Abstract: Data on the validity of pediatric thrombosis diagnoses are missing. We aimed to 
examine the predictive value of a diagnosis of venous and arterial thrombosis using the Dan-
ish National Patient Registry (DNPR). We identified all first-time diagnoses among children 
and adolescents (aged 0–18 years) between 1994 and 2006 in DNPR. In total, 1138 potential 
cases of thrombosis were identified; the medical records were retrieved for 1112 (97.7%) and 
the positive predictive value (PPV) computed. Overall, the diagnosis of thrombosis was veri-
fied in 598 of the 1112 cases, corresponding to a PPV of 53.7% (95% confidence interval [CI]: 
50.8–56.7). Diagnoses from wards had the PPV of 62.5% (95% CI: 59.4–65.6). The predictive 
value of a thrombosis diagnosis from wards was age-dependent, with a higher PPV (77.4%, 
95% CI: 68.7–84.7) in neonates (,28 days) and adolescents (15–18 years) (68.2%; 95% CI: 
63.2–72.5)) than in children (28 days–14 years) (51.2%; (95% CI: 46.0–56.4)). The PPV of a 
thrombosis diagnosis was improved by restricting the analysis to diagnoses from wards, primary 
diagnoses, and admissions with a length of stay of three or more days. The results indicate that 
an interpretation of nonvalidated hospital discharge data for pediatric thrombosis in a registry 
like DNPR should be made with caution.
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Introduction
Thromboembolic disease, including both arterial and venous thrombosis, is generally 
uncommon in children but impacts mortality, chronic morbidity, and childhood devel-
opment. The incidence of pediatric thromboembolism seems to increase in parallel 
with diagnostic and therapeutic advances and decreased mortality in children with 
primary critical illnesses.1
Administrative databases and medical registries are often used in epidemiological 
research and access to such data sources is almost mandatory when conducting large-
scale epidemiological studies of rare diseases, including pediatric thromboembolism. 
However, all data, including data from registries, need to be valid in order to avoid 
misleading results. Validation studies of thrombosis diagnoses in children are lacking, 
though there are several studies on the quality of registry data for arterial2–13 and venous 
thromboembolism in adults.14–18 The aim of the present study was to determine the 
positive predictive value (PPV) of arterial and venous thrombosis diagnoses for 0 to 
18-year-old individuals in the Danish National Patient Registry (DNPR).
Material and methods
The Danish National Health Service provides free, tax-supported health care to the 
entire population of Denmark.19 Information on discharges from Danish hospitals Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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is available in the Danish National Patient Registry, which 
contains data on all discharges since 1977 and all outpa-
tients since 1995.20 The data include the dates of admission 
and discharge, surgical procedure(s) performed, and up to 
20 diagnoses classified according to the International Clas-
sification of Diseases (ICD; 8th revision until the end of 
1993 and the 10th revision thereafter). Discharge diagnoses 
in the registry are determined exclusively by the physician, 
who discharges the patient.
All incident cases in children and adolescents with a first-
time discharge diagnosis of arterial and/or venous thrombosis 
were identified in the DNPR. We only included patients who 
were 0–18 years old and residents of Denmark at the time 
of admission. The study period was restricted to January 1, 
1994 through December 31, 2006. The ICD-10 diagnosis 
codes of thrombosis and number of recorded diagnoses in 
the DNPR are presented in Table 1.
Criteria for diagnoses
A diagnosis of thrombosis was confirmed if documented 
by clinical presentation and supported by findings from 
imaging, surgery, or autopsy. The presence of clinical signs 
was mandatory for confirming a diagnosis. The detailed 
clinical presentation of thrombosis in different age groups 
was reported previously.21–23 We considered the following 
definitions of thrombosis:
Cerebral sinovenous thrombosis (CSVT): any transient 
neurological dysfunction and thrombosis of the cerebral veins 
or venous sinuses demonstrated by computed tomography 
(CT), magnetic resonance (MR) scan, MR venography, and/
or conventional cerebral venography.
Pulmonary embolism (PE): dyspnea, chest pain, hypoxia, 
and cardiac-respiratory collapse combined with findings 
from ventilation-perfusion lung scan, CT, or pulmonary 
angiography.
Deep venous thrombosis (DVT): swelling, pain, and 
discoloration of the extremities or vena cava superior syn-
drome or renal and/or liver dysfunction, and ultrasonogra-
phy ULS/venography/CT/MR findings in agreement with 
thrombosis.
Arterial ischemic stroke (AIS): clinical presentation 
consistent with stroke (ie, neurological deficits, seizures, 
lethargy, or abnormalities in muscle tone) and a CT scan or 
MR showing a focal ischemic infarct of a location and age 
consistent with the neurological signs and symptoms. Patients 
with primary cerebral hemorrhage not associated with AIS 
or CSVT were excluded.
Thrombosis in the arteries of limbs, abdomen, and 
thorax: ischemia of the limb or selected organ dysfunction 
supported by findings from contrast angiography/Doppler 
ultrasonography/CT/MR or surgery. Thrombosis in stents 
and arteriovenous grafts were not included.
Myocardial infarction (MI): symptoms supported by 
electrocardiogram (ECG) and biochemical markers or find-
ings on coronary angiography.
Retinal occlusion: visual problems confirmed by 
ophthalmoscopic examination or by positive findings on 
angiography/CT/MR.
Table 1 iCD-10 diagnoses of thrombosis in children (0–18 years of age) recorded in the Danish national Patient registry (DnPr) 
during the period 1994–2006
Thrombosis localization ICD-10 diagnosis codes Number of first-time diagnoses   
recorded in the DNPR n (%)
Venous Cerebral sinovenous
retinal veins
Pulmonary embolism
Vena cava, renal veins,  
hepatoportal veins
Deep veins of extremities
Venous thrombosis in relation  
to pregnancy
i67.6, i63.6, g0.8
h34.8
i26
i81–i82
i80.1–i80.9
O22.5A, O87.3, O22.3, 
O22.8–9, O87A–F, O87.1
57 (5.0)
4 (0.4)
105 (9.2)
103 (9.1)
391 (34.4)
0
Arterial ischemic stroke
retinal arteries
Arteries of extremities 
and/or aorta
renal arteries
Myocardial infarction
i63–i64
h34.1–h34.2
i74
n28.0A, n28.0D
i21
364 (32.0)
4 (0.4)
61 (5.4)
0
42 (3.7)
Miscellaneous (combined 
arterial and venous)
Mesenterial
retinal
K55.0h, K55.0C
h34, h34.9
0
7 (0.6)
All 1138 (100)Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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Medical record review
Medical records were retrieved and reviewed by a single 
experienced pediatrician (RT) using a detailed standardized 
form developed in collaboration with local and international 
consultants in pediatric hematology/oncology with pediatric 
thrombosis experience. Cerebral and noncerebral thromboses 
were registered in separate forms, focusing on symptoms and 
date of symptoms, imaging, location of the thrombosis, dates 
of diagnosis and treatment, possible causes of not confirming 
the diagnosis in DNPR, choice and effect of treatment, risk 
factors and outcome (Appendices A, B). The review was 
based on all available information in the medical records, 
including results from laboratory tests (coronary biomarkers), 
ECG, and radiology reports. The actual imaging films were 
not re-interpreted, and the assessment was based on written 
reports by a radiologist. The reviewer was not blinded to the 
registered discharge codes.
Ethics
The study was approved by the Danish Data Protection 
Agency (J. no. 2007-41-0539) and the National Board of 
Health (J. no. 7-604-04-2/37/EHE).
statistical analysis
The PPV of the thrombosis diagnoses recorded in the DNPR 
was calculated as a proportion; the numerator was the number 
of patients with a confirmed diagnosis after a review of the 
medical records and the denominator was the total number 
of patients registered with a specific diagnosis. The PPV 
was calculated for all patients and separately for neonates 
(,28 days old) including preterm born neonates (,gestational 
week 37 + 0), children (28 days–14 years old), adolescents 
(15–18 years old), and specific diagnostic categories. Preterm 
born children aged 28 days–14 years at the time of throm  bosis 
were attributed to the age group “children”. Data were also 
stratified by sex, type of hospital department (emergency room 
or ward, including outpatient clinic), length of stay (shorter vs 
3 days or longer), type of diagnosis (primary or secondary), 
type of hospital (university vs regional), and calendar periods 
(1994–1999, 1999–2002, and 2003–2006). The estimation of 
95% confidence intervals (CI) was based on an approximation 
of the PPV to binomial distribution. Data were analyzed using 
STATA statistical software version 10.
Results
Thrombosis diagnoses in the DnPr
A total of 1138 individuals aged 0–18 years residing in 
  Denmark were recorded with a first-time diagnosis of throm-
bosis in the DNPR during the period 1994–2006 (Table 1). 
We were able to retrieve and review medical records from 
1112 (97.7%) of these patients.
Diagnostic tools for diagnosing 
thrombosis
Diagnostic tools used to confirm different types of thrombosis 
are presented in Table 2. MR imaging was used to confirm 
CSVT diagnosis in 84.2% of CSVT cases and AIS in 68.9% 
of AIS cases. The remaining cerebral thromboses were 
documented by CT. Ultrasonography was used to evaluate 
214 of 259 patients (82.6%) with verified diagnoses of DVT, 
whereas contrast angiography alone was used in 30 of 259 
cases (11.6%; Table 2). Findings from coronary angiography 
Table 2 Diagnostic tools for verified diagnosis of symptomatic thrombosis
Diagnostic 
method
Venous thrombosis Arterial thrombosis Retinal 
occlusion
n = 3
n (%)
CSVT
n = 38
n (%)
DVTb
n = 259 
n (%)
PE
n = 48
n (%)
AISc
n = 209
n (%)
Extremities/aorta
n = 37
n (%)
MI
n = 4
n (%)
Mr (± CT) 32 (84.2) 9 (3.5) 1 (2.1) 144 (68.9) 2 (5.4) – –
CT alone 6 (16.2) 9 (3.5) 10 (20.8) 64 (30.3) 2 (5.4) – –
Ultrasonography 
(± other tools)
– 214 (82.6) – – 14 (37.8) – –
Ventilation-perfusion 
lung scan (± other tools)
– – 34 (70.8) – – – –
Angiography alone – 30 (11.6) 1 (2.1) – 13 (35.1) 2 (50.0) 1 (33.3)
Autopsy – – 1 (2.1) – – 1 (25.0) –
Miscellaneousa – – 1 (2.1) – 8 (21.6)d 1 (25.0) 2 (66.7)
Notes:  aMiscellaneous diagnostic tools are i) findings during surgery (PE and arterial thrombosis), ii) biochemical markers and/or electrocardiogram findings in MI, 
iii) ophthalmoscopic examination in retinal occlusion. bMethod of examination was unknown in one patient with DVT in the extremities and abdomen. cType of brain scan 
was unknown in one patient with Ais. dTwo newborns were included based on clinical signs of a threatened limb. imaging or surgery was not performed.
Abbreviations: Ais, arterial ischemic stroke; CT, computed tomography; CsVT, cerebral sinovenous thrombosis; DVT, deep venous thrombosis; Mi, myocardial infarction; 
Mr, magnetic resonance; PE, pulmonary embolism.Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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supported the diagnosis of MI in two patients, whereas   typical 
changes in ECG were seen in one MI case and autopsy 
  findings confirmed the diagnosis in a fourth child.
Positive predictive values
A thrombosis diagnosis was confirmed in 598 of 1112 
patients, corresponding to an overall PPV of 53.7% (95% 
confidence interval [CI]: 50.8–56.7). When diagnoses 
recorded in emergency departments were excluded (n = 176), 
the PPV increased 62.5% (95% CI: 59.4–65.6) (Table 3). 
All diagnoses in neonates were made at wards, while 44 
of 419 children and 132 of 578 adolescents had diagnoses 
from emergency departments. The PPV of diagnoses among 
adolescents and children was 54.7% (95% CI: 50.5–58.8) 
and 46.1% (95% CI: 41.2–51.0), respectively, and increased 
substantially among adolescents when emergency room diag-
noses were excluded (Table 3). Focusing at diagnoses from 
wards, no major differences in PPV between the diagnostic 
categories was found, except for diagnosis of MI (Table 3). 
Variation in the PPV was seen in some specific thrombosis 
diagnoses from wards between the three age groups (Table 3). 
Predictive values of a thrombosis diagnosis from wards were 
age-dependent, with the highest PPV in neonates, and the 
PPV in adolescents higher than in children. The PPV among 
children were lower for venous thromboses and tended to be 
higher for AIS than in adolescents (Table 3).
The PPV of diagnoses from wards also differed accord-
ing to length of hospital stay (shorter vs 3 days or longer), 
and to type of diagnosis (primary vs secondary) (Table 4). 
In contrast, no differences in the PPV were found accord-
ing to gender, different study periods or type of hospital 
(university vs regional) (Table 4).
Almost half of the identified thrombosis diagnoses 
(514/1112) in the DNPR were not confirmed after the validation 
process. The main cause (67.9%) for not being confirmed was 
the absence of findings consistent with thrombosis on imaging 
Table 3 The positive predictive value (PPV) of arterial and venous thrombosis diagnoses in patients aged 0–18 years in the Danish 
national Patient registry
Diagnoses PPV% (95% CI)a, nconfirmed/ntotal
b
All departments Emergency 
departments
Wards
Total Neonates 
(<28 days)
Children 
(28 days–14 years)
Adolescents 
(15–18 years)
Total 53.7 (50.8–56.7) 
598/1112
7.4 (13.5–11.3) 
13/176
62.5 (59.4–65.6) 
585/936
77.4 (68.7–84.7) 
89/115
51.2 (46.0–56.4) 
192/375
68.2 (63.6–72.5) 
304/446
All venous 
thrombosisc
53.9 (50.0–57.8) 
345/640
7.4 (3.6–13.2) 
10/135
66.3 (62.0–70.5) 
335/505
82.4 (65.5–93.2) 
28/34
39.0 (30.4–48.2) 
48/123
74.4 (69.5–78.9) 
259/348
CsVT 66.7 (52.9–78.6) 
38/57
0/2 69.1 (55.2–80.9) 
38/55
87.5 (47.4–99.7) 
7/8
50.0 (29.1–70.9) 
12/24
82.6 (61.2–95.1) 
19/23
PE 47.5 (37.5–57.7) 
48/101
0/25 63.2 (51.3–73.9) 
48/76
0/1 16.7 (2.1–48.4) 
2/12
73.0 (60.4–83.4) 
46/63
Thrombosis of  
vena cava, renal  
veins, hepatoportal 
veins
62.8 (52.6–72.1) 
64/102
9.1 (0.3–41.3) 
1/11
69.2 (58.7–78.7) 
63/91
94.7 (74.0–99.9) 
18/19
52.8 (35.5–69.6) 
19/36
72.2 (54.8–85.8) 
26/36
DVT in extremities 51.3 (46.2–56.5) 
195/380
9.3 (4.3–16–9) 
9/97
65.7 (59.9–71.2) 
186/283
50.0 (11.8–88.2) 
3/6
29.4 (17.5–43.8) 
15/51
74.3 (68.1–79.9) 
168/226
All arterial 
thrombosisd
53.6 (49.0–58.2) 
253/472
7.3 (15.4–19.9) 
3/41
58.0 (53.2–62.7) 
250/431
75.3 (64.5–84.2) 
61/81
57.1 (50.8–63.3) 
144/252
45.9 (35.8–56.3) 
45/98
Ais 58.1 (52.8–63.2) 
209/360
4.6 (1.2–22.8) 
1/22
61.5 (56.1–66.8) 
208/338
73.9 (61.5–84.0) 
48/65
62.3 (55.3–68.9) 
129/207
47.0 (34.6–59.7) 
31/66
Thrombosis in 
arteries of the 
extremities, aorta
62.7 (49.2–75.0) 
37/59
25.0 (0.6–80.6) 
1/4
65.5 (51.4–77.8) 
36/55
92.3 (64.0–99.8) 
12/13
59.1 (36.4–79.3) 
13/22
55.0 (31.5–76.9) 
11/20
Myocardial  
infarction
10.5 (2.9–24.8) 
4/38
7.7 (0.2–36.0) 
1/13
12.0 (2.6–31.2) 
3/25
50.0 (1.3–98.7) 
1/2
12.5 (1.6–38.4) 
2/16
0/7
retinal occlusionse 20.0 (4.3–48.1) 
3/15
0/2 23.1 (5.0–53.8) 
3/13
0/1 0/7 60.0 (14.7–94.7) 
3/5
Notes: a95% confidence interval. bNumber of confirmed diagnoses/number of recorded diagnoses. cincluding cerebral sinovenous thrombosis (CsVT), pulmonary embolism 
(PE), and deep venous thrombosis (DVT) in the extremities and miscellaneous veins. dincluding arterial ischemic stroke (Ais), thrombosis in the arteries of limbs and aorta, 
myocardial infarction (Mi), and retinal occlusions. eOne arterial, one venous, one bland.
Abbreviation: CI, confidence interval.Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
111
PPV of pediatric thrombosis diagnoses
tests or a lack of imaging required to support the diagnosis of 
thrombosis (Table 5). An imaging test was not performed in 94 
of 380 patients registered with a discharge diagnosis of DVT in 
the extremities and in 36 of 101 recorded PE diagnoses. Imaging 
confirmed primary cerebral   hemorrhage was found in 7.5% of 
the patients registered with a diagnosis of AIS. Coding errors, 
defined as inaccuracies in coding the discharge diagnosis or 
incorrect data entry into a registry, were seen overall in 20.6% 
of possible thrombosis diagnoses. An accidental incorrect data 
entry was particularly frequent for rare diagnoses in children, 
specifically MI, retinal occlusion, and CSVT (Table 5).
Discussion
We found that only 53.7% of all pediatric thrombosis diag-
noses registered in the DNPR could be confirmed after a 
review of the medical records. However, the registry also 
includes diagnoses from emergency rooms, and stratifica-
tion by hospital departments increased the overall PPV , in 
particular the PPV among adolescents. The highest predictive 
values were associated with discharge diagnosis from a ward, 
primary diagnoses, a hospital stay of three or more days, and 
diagnoses made in neonates and adolescents.
To the best of our knowledge, the present study is the 
first to evaluate the quality of pediatric thrombosis diag-
noses in an administrative registry. In adults, a PPV of 
74%–84% has been reported for VTE14,16,17 and 65%–97% 
for arterial thromboembolism, including ischemic stroke 
2–4,6,7,13,24 and coronary disease.8–12 The PPV of VTE diagno-
sis has also been examined in cohorts of women in relation 
to pregnancy, reporting predictive values of 80%.16,18 These 
validation studies are essential in epidemiological and clini-
cal studies of thrombosis; however, the results can not be 
Table 4 The positive predictive value (PPV) of discharge diagnoses 
of venous and arterial thrombosis in the subgroup of in-patients 
(0–18 years) in the Danish national Patient registry (DnPr)
Subgroups n PPV% (95% CI)
Male 400 62.5 (57.6–67.3)
Female 536 62.5 (58.3–66.6)
Primary diagnosis 615 66.8 (63.0–70.5)
secondary diagnosis 321 54.2 (48.6–59.8)
hospital stay ,3 days 334 44.6 (39.2–50.1)
hospital stay $3days 602 72.4 (68.7–76.0)
University hospitals 354 64.4 (59.2–69.4)
regional hospitals 582 61.3 (57.3–65.3)
study periods:
1994–1998 321 61.4 (55.8–66.7)
1999–2002 278 63.0 (57.0–68.6)
2003–2006 337 63.2 (57.8–68.4)
Abbreviations: n, recorded diagnoses in DNPR; CI, confidence interval.
Table 5 Unconfirmed thrombosis diagnoses
Registered thrombosis 
diagnosis
Unconfirmed diagnoses
Total
n
Asymptomatic 
course
n (%)
Lack of confirmation 
from imaging
n (%)
Incorrect code
n (%)
Miscellaneousa
n (%)
CsVT
n = 57
19 0 7 (36.8) 9 (47.4) 3 (15.8)
PE
n = 101
53 2 (3.8) 41 (77.4) 8 (15.1) 2 (3.8)
Thrombosis of vena cava, 
renal veins, hepatoportal 
veins
n = 102
38 6 (15.8) 20 (52.6) 8 (21.1) 4 (10.6)
DVT in extremities 
n = 380
185 1 (0.5) 157 (84.9) 26 (14.1) 1 (0.5)
Ais
n = 360
151 6 (4.0) 102 (67.6)  23 (15.2) 20 (13.3)
Thrombosis in arteries  
of the extremities, aorta
n = 59
22 1 (4.6) 14 (63.6) 4 (18.2) 3 (13.6)
Mi n = 38 34 0 6 (17.7) 19 (55.9) 9 (26.5)
retinal occlusions n = 15 12 1 (8.3) 2 (16.7) 8 (66.7) 1 (8.3)
Total
n = 1112
514 17 (3.3) 349 (67.9) 105 (20.4) 43 (8.4)
Notes: aMiscellaneous causes for exclusion: i) diagnosis before or after study period, ii) thrombosis in stents (n = 2 arterial noncerebral), iii) diagnosis of thrombosis due to 
meningococcal infection (n = 1 arterial noncerebral), iv) lack of supporting ophthalmoscopic findings in retinal occlusions and biochemical markers and/or electrocardiogram 
findings in MI.
Abbreviations: Ais, arterial ischemic stroke; CsVT, cerebral sinovenous thrombosis; DVT, deep venous thrombosis; Mi, myocardial infarction; PE, pulmonary embolism.Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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extrapolated to thrombosis studies in children. The epide-
miology and pathophysiology of thromboembolic disease 
in children is vastly different from what is seen in adults. 
Differences in the coagulation system during childhood and 
a constellation of endogenous and exogenous thrombophilic 
risk factors in children make pediatric thrombosis unique. 
In particular, neonates should be considered a separate 
population, different from older children, and several 
thromboembolic diseases, such as ischemic arterial stroke, 
are not comparable to AIS in adults.25 Therefore, results 
from studies in adults can not be generalized to studies of 
thrombosis in children.
A few studies have examined the quality of   pediatric 
diagnoses in administrative databases. Diagnoses in 
children in the DNPR were examined in 1995 as a whole 
(no specification of diseases) and the PPV found to be 
73.3%.20 Recently, pediatric diagnoses of asthma and 
febrile seizures in the DNPR were described to have high 
predictive values of 85.0% and 92.8%, respectively.26,27 
Furthermore, the PPV of childhood cancer diagnoses was 
estimated to be 97.1% in the nationwide Danish Cancer 
Registry.28 In contrast, the overall PPV of diagnoses of 
thrombosis from wards in our study was much lower, only 
62.5%. Thus, the diagnoses of thromboembolic diseases in 
the registry are more uncertain than diagnoses of cancer, 
febrile seizures, and asthma. However, the PPV of more 
homogenous groups and specific diagnoses in certain age 
groups (eg, VTE and CSVT in newborns with a PPV of 
82.4%) were comparable to the other validation studies of 
pediatric diagnoses.
The population in our study was divided into three 
groups: neonates (,28 days), children (28 days–14 years), 
and adolescents (15–18 years). The relatively high PPV of 
diagnoses in newborns probably reflects their treatment in 
subspecialized neonatal divisions of pediatric departments. 
Children younger than 15 years of age are normally admitted 
directly to the pediatric departments in the hospitals taking 
care of all acute admissions, whereas adolescents older than 
15 years of age are administratively assigned to adult wards. 
Emergency room diagnoses represent mostly “suspected” 
diagnoses, whereas the subsequent diagnostic steps and 
treatment are performed in the ward. We found a PPV of 
7.4% for pediatric thrombosis diagnoses from emergency 
rooms. A low predictive value of thrombosis diagnoses from 
emergency rooms has also been reported among adults.3,11,17 
A variation of 2.5%–90% in the agreement between diag-
nosis groups from clinical and administrative data sources 
has been found in pediatric emergency departments.29 How-
ever, thrombosis diagnoses were not among the diagnoses 
in that study. To the best of our knowledge, the low validity 
of emergency room diagnoses of pediatric thrombosis was 
not reported previously, and the findings might be important 
when conducting further studies.
Generally, there was no disagreement between the 
diagnosis in the medical records and the conclusion of our 
record review. The most common cause of nonconfirmed 
diagnoses was situations when suspicion of thrombosis 
was raised, but the diagnosis was ruled out by the objec-
tive examination or by imaging. In such situations, a code 
“observation for thrombosis” is supposed to be used but was 
not. Thus, the major cause of nonconfirmed diagnoses was 
incorrect coding rather than incorrect diagnostic work-up 
and diagnosis.
A wide range of medical conditions was identified 
among the cases where cerebral thrombosis could not be 
verified, including hypoxic–ischemic encephalopathy due 
to perinatal asphyxia, Todd’s paralysis, intracerebral hemor-
rhage, migraine, and severe headache. Few patients with 
a diagnosis of arterial ischemic stroke had thrombosis in 
cerebral veins. When noncerebral thrombosis was ruled 
out, no alternative diagnosis could be made in the majority 
of cases. In some cases, however, a different diagnosis was 
made by the physician, such as rupture of muscle fiber or 
superficial thrombophlebitis instead of DVT, and muscle 
pain or hyperventilation rather than PE.
The quality of data from administrative registries can be 
affected by errors in the data set. In our study, incorrect data 
entry was seen according to individual diagnosis codes in the 
DNPR and found in half of the recorded diagnoses of AMI 
(“I21” instead of “Q21” for congenital heart disease) and 
retinal occlusion (“H34” instead of “B34” for unspecific virus 
infection).
strengths and limitations
Our study has the strength that it is based on the whole popula-
tion in a country; thus, the findings are representative of the 
nationwide registry. The estimated incidence of symptomatic 
VTE and AIS in children is 0.07/10,000 and 0.1/10,000 person 
years, respectively.30,31 Thus, only large multi-center studies 
or population-based studies are able to assemble the epide-
miological data required for the interpretation of the results. 
Our study was based on all first-time diagnoses of thrombosis 
in 0–18-year-old individuals over 13 years in a country with 
5.5 million inhabitants.32 All residents have a unique personal 
registration number, which ensured a valid linking of informa-
tion between the DNPR and medical records. Diagnoses in the 
registry were according to ICD-10, and all possible thrombosis 
diagnoses were identified in the examination in order to not miss Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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any cases of thrombosis in the DNPR; for example, additional 
diagnoses of thrombosis in relation to pregnancy in teenage girls 
were included in the search, but none were found. The retrieval 
of medical records for possible thrombosis diagnoses was nearly 
complete; only 26 of 1138 records could not be found. The 
confirmation of thrombosis diagnosis was based on available 
information in the medical records, which may not be a perfect 
gold standard; however, we found the clinical information to be 
detailed and properly documented.
However, there are also some limitations to our study. 
Finding a thrombus in the imaging results without any 
symptoms (screening) was not considered a criterion for the 
verification of a diagnosis in our study. Overall, 1.5% of iden-
tified diagnoses (17/1112) were found to be   asymptomatic. 
Additionally, two children had thrombi in stents and were not 
included in the analysis. These factors reduced the calculated 
PPV , but only to a minimal degree.
All records were reviewed by the same person. Therefore, 
the decisions are consistent, but they also rely on the judgment 
of this person. However, the forms that were used to make the 
judgments were developed in collaboration with other experi-
enced clinicians, and all uncertain cases were discussed.
In our study we have not been able to asses the sensitivity, 
completeness and negative predictive value of DNPR because 
we had no method to track cases not registered in the DNPR. 
The vast majority of pediatric patients with such a severe 
disease are likely to be hospitalized, however, thrombosis 
diagnoses may be missed in the DNPR if the thrombosis is not 
considered to be a secondary diagnosis in a severe course of a 
complex disease (eg, pediatric cancer). An independent data 
source (eg, a pediatric thrombosis registry) would be needed in 
order to get further insights into the accuracy of the DNPR.
In conclusion, the overall positive predictive values of 
pediatric thrombosis diagnoses were low to moderate. The 
PPV might be improved by restricting the data to diagnoses 
from wards, patients with primary diagnoses, and admissions 
with a length of stay of 3 days or more. Thus, the use and 
interpretation of nonvalidated data on pediatric thromboem-
bolism from the DNPR should only be done with caution.
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Appendix A
Cerebral thrombosis in children
Date of collection: ………/…………/……………..
Hospital: …………
Department: …………
Patient ID number: …………………………………….
______________________________________________________________________________
1. Symptoms:   yes   no   unknown
  seizures   n.facialis paresis
  altered mental status   hemiparesis
  other …………………………………………..
Date of start of symptoms: ……../………/…………….   unknown
2. Imaging performed:   yes   no   unknown
  CT ± angio ………………………. confirming thrombosis:   yes   no   unknown
  MR ± angio ……………………… confirming thrombosis:   yes   no   unknown   other 
……………………………… confirming thrombosis:   yes   no   unknown
3. Pt. included:   yes   no
If not, cause:   no symptoms   no radiologic findings   error in coding   other
4. Location of thrombosis i CNS:
  arterial   right side
  venous   left side
Arterial CNS thrombosis:
  a. cerebri media   a. basilaris
  a. vertebralis   other ………………………………………………
Venous CNS thrombosis:
  sinus sagitalis superior   internal veins
  sinus transversus   other ……………………………………………...
Presence of simultaneous hemorrhage:   yes   no   unknown
5. Date of diagnosis of thrombosis: ……./……../……….   unknown
6. Antithrombotic treatment:   yes   no   unknown
  LMWH
Medication: ……………………………………………………..   unknown
Dose/kg/day: ……………………..………..   unknown
Date of start: ………../…….../……………   unknown
Date of completion: ………/……../……………….   no   unknown
  UFH
Dose/kg/day: ……………………..…………   unknown
Date of start: ………../…….../……………   unknownClinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
116
Tuckuviene et al
Date of completion: ………/……../……………….   no   unknown
  Aspirin
Dose/kg/day: ……………………..………..   unknown
Date of start: ………../…….../……………   unknown
Date of completion: ………/……../……………….   no   unknown
  Warfarin
Date of start: ………../…….../……………   unknown
Date of completion: ………/……../………………..   no   unknown
  Other
Medication: ……………………………………………………….   unknown
Date of start: ………../…….../……………   unknown
Date of completion: ………/……../……………….   no   unknown
7. Monitoring of LMWH treatment by P-antifactor Xa
  yes   no   unknown
8. Bleeding during antithrombotic treatment:   yes   no   unknown
Location: ………………………………................   unknown
Immediate intervention needed:   yes   no   unknown
Blood transfusion needed due to bleeding during antithrombotic treatment:   yes   no   unknown
9. Other complications to antithrombotic treatment:   yes   no   unknown
If yes, describe: …………………………………………………………………
10. SVT resolution examined:   yes   no   unknown
If yes,
  CT ± angio
  MR ± angio
SVT resolution: ………./………/…………..   yes   no
  completely   partial   unknown
11. Neurological sequelae after 1 year (± 3 months):   yes   no   unknown
  epilepsy   motor impairment/disability   cognitive problems
  other: ………………………………………………………………………………………………
Risk factors
12. Did pt. experience thrombosis before:   yes   no   unknown
If yes, date of 1. thrombosis: ……../………./…………    unknown
Location of 1. thrombosis: …………………………………………………………..   unknown
Prophylactic antithrombotic treatment after 1. thrombosis:   yes   no   unknown
If yes, medication: …………………………………………………………………………………
Completed:   yes   no   unknown
If yes, date of completion: ……../………/………………………………………..……   unknownClinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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13. Disposition:
Parents or siblings with thrombosis:   yes   no   unknown
Documented inherited thrombophilia in parents or siblings:   yes   no   unknown
If yes, describe: ………………………………………………………………………………………..
14. Underlying cancer:   yes   no   unknown
If yes, diagnosis:   leukemia/lymphoma   CNS tumor   other
Protocol of treatment: ………………………………………………………………….   unknown
Phase of treatment during thrombosis: …………………………………………………   unknown
Treatment with asparaginase by the occurrence of thrombosis:   yes   no   unknown
Last dose of asparaginase before thrombosis: ….../……../…………   unknown
Type of asparaginase:
  Erwinase   E. coli asparaginase   PEG asparaginase   unknown
Asparaginase stopped/dose decreased due to thrombosis?   yes   no   unknown
15. Treatment by occurrence of thrombosis:
Steroids:   yes   no   unknown
(  prednisolone   prednisone   dexamethasone   other)
TPN:   yes   no   unknown
Oral contraceptive:   yes   no   unknown
16. Varicella infection before AIS:   yes   no   unknown
If yes, date: ……./…………………   unknown
17. Infection by the time of admission:   yes   no   unknown
Type: ………………………………………………………….   unknown
Antibiotic treatment:   yes   no   unknown
Fever .37.5:   yes   no   unknown
18. CVL:   yes   no   unknown
Date of the last insertion: ..….../……../………………………………………………..…   unknown
Type:   subcutane port   extern tunneled   extern untunneled   unknown
Location:   yes   unknown
If yes,
  right-sided   OE
  left-sided   UE
Vein: …………………………………………………………………………………   unknown
CVL removed:   yes   no   unknown
Cause:
  thrombosis    infection    otherClinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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19. Arterial catheter:   yes   no   unknown
Date of insertion: ..…/……/…………………………..   unknown
Artery: ………………………………………………...   unknown
20.
Risk factors within 3 months yes no unknown
Surgery
Immobilization ($4 days)
Trauma
21. Other underlying diseases:   yes   no   unknown
If yes, describe: ……………………………………………………………………………………
22. Thrombophilia:
No work-up:   yes → end of scheme
Tested yes no unknown
Protein C 
Protein S 
Antithrombin 
Fibrinogen 
Lupus anticoagulant 
Cardiolipin antibodies IgM 
Cardiolipin antibodies IgG 
Beta-2-glycoprotein-1 IgM 
Beta-2-glycoprotein-1 IgG 
Activated protein C resistance 
Factor V mutation Leiden G1691A 
Factor II mutation G20210A
Homocysteine
Lipoprotein(a) 
Factor VIII 
Documented defect:   yes   no   unknown
If yes, describe: …………………………………………………………………………..Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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Appendix B
Noncerebral thrombosis in children
Date of collection: ………/…………/……………..
Hospital: ……………...
Department: …………
Patient ID number: ………………………………………….
1. Symptoms:   yes   no   unknown
Date of start of symptoms: ……../………/…………….   unknown
2. Imaging performed:   yes   no   unknown
  ULS ± Doppler ………………………. confirming thrombosis:   yes   no   unknown
  Contrast veno/arteriography …………..… confirming thrombosis:   yes   no   unknown
  CT ± angio …………………………..… confirming thrombosis:   yes   no   unknown
  MR ± angio …………………………… confirming thrombosis:   yes   no   unknown
3. Pt. included:   yes   no
If no, reason:   no symptoms   no radiologic findings   error in coding   other
4. Location of thrombosis:
Venous thrombosis:   yes
  DVT in UE   v. cava inferior   v. cava superior
  v. iliaca   v. lienalis   intracard right
  v. femoralis   v. portae   v. subclavia
  v. mesenterica   v. hepatica   v. jugularis
  v. renalis   PE
  other ……………………………………………………………………………………………….
Arterial thrombosis:   yes
  a. femoralis   a. mesenterica   intracard left
  a. iliaca   a. renalis   a. retinae
  aorta abdominalis   a. hepatica   a. brachialis
  other ……………………………………………………………………………………………….
Side:   yes   no   unknown
If yes,
  right
  left
5. Date of diagnosis: ……./……../……..….   unknown
6. Antithrombotic treatment:   yes   no   unknown
  LMWH
Medication: ……………………………………………………….   unknown
Dose/kg/day: ……………………..…….….   unknown
Date of start: ………../…….../……………   unknown
Date of completion ………/……../……………….   no   unknownClinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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  UFH
Dose/kg/day: ……………….……..……….   unknown
Date of start: ………../…….../……………   unknown
Date of completion ………/……../……………….   no   unknown
  Aspirin
Dose/kg/day: ……………………..….…….   unknown
Date of start: ………../…….../……………   unknown
Date of completion ………/……../……………….   no   unknown
  Warfarin
Date of start: ………../…….../……………   unknown
Date of completion ………/……../……………….   no   unknown
  Other
Medication: ………………………………………………………...   unknown
Date of start: ………../…….../……………   unknown
Date of completion ………/……../……………….   no   unknown
7. Monitoring of LMWH treatment by P-antifactor Xa
  yes   no   unknown
8. Embolectomy:   yes   no   unknown
9. Bleeding during antithrombotic treatment:   yes   no   unknown
Location: ………………………………..............   unknown
Immediate intervention needed:   yes   no   unknown
Blood transfusion needed due to bleeding during antithrombotic treatment:   yes   no   unknown
10. Other complications of antithrombotic treatment:   yes   no   unknown
If yes, describe: …………………………………………………………………
11. Resolution examined:   yes   no   unknown
  ULS ± Doppler
  contrast venography
  MR ± angio
  CT ± angio
Resolution confirmed: ………./………/…………..   no   unknown
  completely   partial   unknown
12. Sequelae after 1 year (± 3 months):   yes   no   unknown
If yes, describe ………………………………………………………………………………………...
Risk Factors
13. Did pt. experience thrombosis before:   yes   no   unknown
If yes, date of 1. thrombosis: ……../………./…………   unknown
Location of 1. thrombosis: ……………………………………………………………   unknown
Prophylactic antithrombotic treatment after 1. thrombosis:   yes   no   unknownClinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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If yes, medication: …………………………………………………………………………………
Completed:   yes   no   unknown
If yes, date of completion: ……../………/………………………………………..…...   unknown
14. Disposition:
Parents or siblings with thrombosis:   yes   no   unknown
Documented inherited thrombophilia in parents or siblings:   yes   no   unknown
If yes, what: ………………………………………………………………………………………..
15. Underlying cancer:   yes   no   unknown
If yes, diagnosis:   leukemia/lymphoma   CNS tumor   other
Protocol of treatment: …………………………………………………………………..   unknown
Phase of treatment during thrombosis: …………………………………………………   unknown
Treatment with asparaginase by the occurrence of thrombosis:   yes   no   unknown
Last dose of asparaginase before thrombosis: ….../……../…………   unknown
Type of asparaginase:
  Erwinase   E. coli asparaginase   PEG asparaginase   unknown
Asparaginase stopped/decreased dose due to thrombosis?   yes   no   unknown
16. Treatment by occurrence of thrombosis:
Steroids:   yes   no   unknown
(  prednisolone   prednisone   dexamethasone   other)
TPN:   yes   no   unknown
Oral contraceptive:   yes   no   unknown
17. Infection by the time of admission:   yes   no   unknown
Type: ………………………………………………………….   unknown
Antibiotic treatment:   yes   no   unknown
Fever .37.5:   yes   no   unknown
18. CVL:   yes   no   unknown
Date of the last insertion: ..….../……../………………………………………………..…   unknown
Type:   subcutane port   extern tunneled   extern untunneled   unknown
Location:   yes   unknown
If yes,
  right-sided   OE
  left-sided   UE
Vein: …………………………………………………………………………………   unknown
CVL removed:   yes   no   unknown
Cause:
  thrombosis   infection   otherClinical Epidemiology
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19. Arterial catheter:   yes   no   unknown
Date of insertion: ..…/……/…………………………...   unknown
Artery: …………………………………………………   unknown
20.
Risk factors within 3 months yes no unknown
Surgery
Immobilization ($4 days)
Trauma
21. Other underlying diseases:   yes   no   unknown
If yes, describe: ……………………………………………………………………………………
22. Thrombophilia:
No work-up:   yes → end of scheme
Tested yes no unknown
Protein C 
Protein S 
Antithrombin 
Fibrinogen 
Lupus anticoagulant 
Cardiolipin antibodies IgM 
Cardiolipin antibodies IgG 
Beta-2-glycoprotein-1 IgM 
Beta-2-glycoprotein-1 IgG 
Activated protein C resistance 
Factor V mutation Leiden G1691A 
Factor II mutation G20210A
Homocysteine
Lipoprotein(a) 
Factor VIII 
Documented defect:   yes   no   unknown
If yes, describe: …………………………………………………………………………..